Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2006

01-12-2006 | Original Paper

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

Authors: Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, Abigail Crocker, Donald Weaver, Lynn Dressler, Donald Berry, Linda Sutton, Richard Michaelson, Michael Messino, Jeffrey Kirshner, Gini Fleming, Eric Winer, Clifford Hudis, Stacy Appel, Larry Norton, Hyman Muss, for the Cancer and Leukemia Group B

Published in: Breast Cancer Research and Treatment | Issue 3/2006

Login to get access
Metadata
Title
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Authors
Mercedes Rincon
Gloria Broadwater
Lyndsay Harris
Abigail Crocker
Donald Weaver
Lynn Dressler
Donald Berry
Linda Sutton
Richard Michaelson
Michael Messino
Jeffrey Kirshner
Gini Fleming
Eric Winer
Clifford Hudis
Stacy Appel
Larry Norton
Hyman Muss
for the Cancer and Leukemia Group B
Publication date
01-12-2006
Published in
Breast Cancer Research and Treatment / Issue 3/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9251-7

Other articles of this Issue 3/2006

Breast Cancer Research and Treatment 3/2006 Go to the issue

Clinical Epidemiology

Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin?

Epidemiology

Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study

CLINICAL TRIAL

Computed tomography in suspected local breast cancer recurrence

Abstracts

Late-breaking abstracts

Letter to the Editor

Albumin-Bound Paclitaxel, ABI-007 May Show Better Efficacy than Paclitaxel in Basal-Like Breast Cancers: Association Between Caveolin-1 Expression and ABI-007

Clinical Trial

Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5 years' Adjuvant Treatment for Early Breast Cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits